| 1 |
Perez-Torrado, R., Yamada, D. and Defossez, P. A. (2006) Born to bind: the BTB protein-protein interaction domain. Bioessays 28, 1194-1202.
DOI
ScienceOn
|
| 2 |
Lee, S. U. and Maeda, T. (2012) POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function. Immunol. Rev. 247, 107-119.
DOI
ScienceOn
|
| 3 |
Kelly, K. F and Daniel, J. M. (2006) POZ for effect--POZ-ZF transcription factors in cancer and development. Trends. Cell Biol. 16, 578-587.
DOI
ScienceOn
|
| 4 |
Costoya, J. A. (2007) Functional analysis of the role of POK transcriptional repressors. Brief. Funct. Genomic. Proteomic. 6, 8-18.
DOI
ScienceOn
|
| 5 |
Zheng, J., Xiong, D., Sun, X., Wang, J., Hao, M., Ding, T., Xiao, G., Wang, X., Mao, Y., Fu, Y., Shen, K. and Wang, J. (2012) Signification of hypermethylated in cancer 1 (HIC1) as tumor suppressor gene in tumor progression. Cancer Microenviron 5, 285-293.
DOI
ScienceOn
|
| 6 |
Albagli-Curiel, O. (2003) Ambivalent role of BCL6 in cell survival and transformation. Oncogene 22, 507-516.
DOI
ScienceOn
|
| 7 |
Wu, W. S. (2006) The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 25, 695-705.
|
| 8 |
Polo, J. M., Dell'Oso, T., Ranuncolo, S. M., Cerchietti, L., Beck, D., Da silva, G. F., Prive, G. G., Licht, J. D. and Melnick, A. (2004) Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells. Nat. Med. 10, 1329-1335.
DOI
ScienceOn
|
| 9 |
Kim, K., Chadalapaka, G., Lee, S. O., Yamada, D., Sastre-Garau, X., Defossez, P. A., Park, Y. Y., Lee, J. S. and Safe, S. (2012) Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer. Oncogene 31, 1034-1044.
DOI
ScienceOn
|
| 10 |
Finkel, T. (2011) Signal transduction by reactive oxygen species. J. Cell Biol. 194, 7-15.
DOI
ScienceOn
|
| 11 |
Sena, L. A. and Chandel, N. S. (2012) Physiological roles of mitochondrial reactive oxygen species. Mol. Cell 48, 158-167.
DOI
ScienceOn
|
| 12 |
Dixon, S. J. and Stockwell, B. R. (2014) The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 10, 9-17.
DOI
|
| 13 |
Trachootham, D., Alexandre, J. and Huang, P. (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?. Nat. Rev. Drug. Discov. 8, 579-591.
DOI
ScienceOn
|
| 14 |
Vazquez, F., Lim, J. H., Chim, H., Bhalla, K., Girnun, G., Pierce, K., Clish, C. B., Granter, S. R., Widlund, H. R., Spiegelman, B. M. and Puigserver, P. (2013) PGC1alpha expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell 23, 287-301.
DOI
ScienceOn
|
| 15 |
Trachootham, D., Zhou, Y., Zhang, H., Demizu, Y., Chen, Z., Pelicano, H., Chiao, P. J., Achanta, G., Arlinghaus, R. B., Liu, J. and Huang, P. (2006) Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 10, 241-252.
DOI
ScienceOn
|
| 16 |
Cho, J. H., Kim, M. J., Kim, K. J. and Kim, J. R. (2012) POZ/BTB and AT-hook-containing zinc finger protein 1 (PATZ1) inhibits endothelial cell senescence through a p53 dependent pathway. Cell Death Differ. 19, 703-712.
DOI
|
| 17 |
Park, H. J., Carr, J. R., Wang, Z., Nogueira, V., Hay, N., Tyner, A. L., Lau, L. F., Costa, R. H. and Raychaudhuri, P. (2009) FoxM1, a critical regulator of oxidative stress during oncogenesis. EMBO J. 28, 2908-2918.
DOI
ScienceOn
|
| 18 |
Raj, L., Ide, T., Gurkar, A. U., Foley, M., Schenone, M., Li, X., Tolliday, N. J., Golub, T. R., Carr, S. A., Shamji, A. F., Stern, A. M., Mandinova, A., Schreiber, S. L. and Lee, S. W. (2011) Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475, 231-234.
DOI
ScienceOn
|
| 19 |
Valentino, T., Palmieri, D., Vitiello, M., Pierantoni, G. M., Fusco, A. and Fedele, M. (2013) PATZ1 interacts with p53 and regulates expression of p53-target genes enhancing apoptosis or cell survival based on the cellular context. Cell Death Dis. 4, e963.
DOI
|
| 20 |
Singh, A., Misra, V., Thimmulappa, R. K., Lee, H., Ames, S., Hoque, M. O., Herman, J. G., Baylin, S. B., Sidransky, D., Gabrielson, E., Brock, M. V. and Biswal, S. (2006) Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 3, e420.
DOI
|
| 21 |
Barrett, C. W., Smith, J. J., Lu, L. C., Markham, N., Stengel, K. R., Short, S. P., Zhang, B., Hunt, A. A., Fingleton, B. M., Carnahan, R. H., Engel, M. E., Chen, X., Beauchamp, R. D., Wilson, K. T., Hiebert, S. W., Reynolds, A. B. and Williams, C. S. (2012) Kaiso directs the transcriptional corepressor MTG16 to the Kaiso binding site in target promoters. PLoS One 7, e51205.
DOI
|
| 22 |
Boulay, G., Dubuissez, M., Van Rechem, C., Forget, A., Helin, K., Ayrault, O. and Leprince, D. (2012) Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteins. J. Biol. Chem. 287, 10509-10524.
DOI
|
| 23 |
Irani, K., Xia, Y., Zweier, J. L., Sollott, S. J., Der, C. J., Fearon, E. R., Sundaresan, M., Finkel, T. and Goldschmidt-Clermont, P. J. (1997) Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275, 1649-1652.
DOI
ScienceOn
|
webmaster
